Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
The expression of carbamoyl phosphate synthetase I (CPS) gene is suppressed in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice at weaning and under starvation at adult age. To clarify the suppression mechanism, we produced CPSL transgenic JVS mice carrying a transgene composed of the chloramphenicol acetyltransferase (CAT) gene with the upstream region (-12 kb to +138) of the rat CPS gene and CPSE transgenic JVS mice carrying a transgene composed of the luciferase gene with minimal promoter (299 bp from -161 to +138) and enhancer (469 bp around -6.3 kb) fragments of the rat gene. The expression of the CAT gene as well as the endogenous CPS was suppressed in CPSL transgenic JVS mice, but luciferase gene expression was not suppressed in CPSE transgenic JVS mice. We isolated the 5'-upstream region of the mouse CPS gene and identified an activator protein-1 (AP-1) site downstream of the minimum enhancer region of both rat and mouse CPS genes. In conjunction with the 313-bp mouse promoter region, the 714-bp mouse enhancer fragment conferred a cell-type-dependent hormone responsiveness. In rat primary cultured hepatocytes, the addition of oleic acid suppressed reporter gene expression induced by dexamethasone in the construct containing the enhancer fragment of 714 bp with the AP-1 site, but not in its AP-1 site mutants or in 519 bp without the AP-1 site. These results strongly suggest that direct protein-protein interaction between AP-1 and glucocorticoid receptor is not involved in the suppression of the CPS gene in JVS mice and that the AP-1 element is the cis-element which is responsible for the suppression.
Abdullah Abu Musa
D M
DM
Faculty of Medicine, Department of Biochemistry, Kagoshima University, Kagoshima University Dental School, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
Kobayashi
K
K
Yasuda
I
I
Iijima
M
M
Christoffels
V M
VM
Tomomura
M
M
Horiuchi
M
M
Ohnishi
T
T
Kajihara
T
T
Daikuhara
Y
Y
Lamers
W H
WH
Saheki
T
T
D000818:Animals; D001665:Binding Sites; D002222:Carbamoyl-Phosphate Synthase (Ammonia) / Q000096:biosynthesis / Q000235:genetics*; D002331:Carnitine / Q000172:deficiency*; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D003001:Cloning, Molecular; D004195:Disease Models, Animal; D004742:Enhancer Elements, Genetic; D004794:Enzyme Repression; D015971:Gene Expression Regulation, Enzymologic; D017930:Genes, Reporter; D008099:Liver / Q000201:enzymology*; D008114:Liver Neoplasms, Experimental; D008156:Luciferases / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic; D051381:Rats; D015183:Restriction Mapping; D018808:Transcription Factor AP-1 / Q000378:metabolism; D014407:Tumor Cells, Cultured
D018808:Transcription Factor AP-1; D008156:Luciferases; D015500:Chloramphenicol O-Acetyltransferase; D002222:Carbamoyl-Phosphate Synthase (Ammonia); D002331:Carnitine